Showing results (11-20 of 528) with videos related to

Sort By:
Pageof 53
International Journal of Peptide and Protein Research|July 1, 1994
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoguesA Misicka, A W Lipkowski, R Horvath, et al.
Life Sciences|January 1, 1992
Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphinA Misicka, A W Lipkowski, R Horvath, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalinA W Lipkowski, A Misicka, P Davis, et al.
Acta Neurochirurgica. Supplement|January 1, 1997
Transport of human beta-amyloid peptide through the rat blood-brain barrier after global cerebral ischemiaR Pluta, A Misicka, S Januszewski, et al.
Life Sciences|May 7, 1998
[125I-Tyr1]biphalin binding to opioid receptors of rat brain and NG108-15 cell membranesJ Slaninova, S M Appleyard, A Misicka, et al.
Neuroreport|May 17, 1996
Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's beta-amyloid-(1-42)-peptideR Pluta, M Barcikowska, S Januszewski, et al.
International Journal of Peptide and Protein Research|September 1, 1995
A topographical model of mu-opioid and brain somatostatin receptor selective ligands. NMR and molecular dynamics studiesW M Kazmierski, R D Ferguson, A W Lipkowski, et al.
Biochemical and Biophysical Research Communications|November 14, 1991
Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activityA Misicka, A W Lipkowski, L Fang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogsS J Weber, T J Abbruscato, E A Brownson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeabilityD L Greene, V S Hau, T J Abbruscato, et al.
Pageof 53